Ping An Biomedical Co., Ltd.

PASW Consumer Cyclical Textile Manufacturing

Ping An Biomedical Co., Ltd.’s revenue for fiscal 2025 (year ended September 2025) was $4.8 million, down 61.6% from fiscal 2024.

0.12 0.01 −7.69%
Market cap
$16.7M
P/E
—
Fwd P/E
—
Dividend yield
—
F-score
n/a
Altman Z
4.30
Beneish M
−2.88
Dividend safety
n/a

Insider Decisions trades per month

Total sells 0.54
Totals in millions of $.
Dec 25 Mar 26 Jun 26 Sep 26
Buy — — — — — — — — — — — —
Sell 2 — — — — — — — — 2 2 —
Insider Ownership —

Capital & Financial Ratios $m

Market Cap 16.72
Revenue —
Net Income (1.87)
Free Cash Flow 1.38
Net Debt (3.77)
Current Ratio 2.54 (at or above 1.5: strong)
Debt/Equity 0.13 (at or below 0.5: strong)
P/E ratio —
Fwd P/E —
P/S ratio —
P/B ratio 0.00
Past 5Y EPS Growth —
This Y EPS Growth (25.00%) (below 0%: weak)
Next Y EPS Growth —
Next Y revenue growth —
Next 5Y EPS Growth —

Green and red mark values outside typical ranges. How we judge →

Valuation vs history

Dividends

Payout Ratio —
Annual Dividend Rate —
Annual Dividend Yield —

Assets vs Liabilities $m

2023 2024 2025 Q'26
Cash — 0 5 5
Receivables — 6 2 1
Inventory — 0 0 —
Other — 2 1 2
— 8 9 8
2023 2024 2025 Q'26
Payables — 2 1 0
ST’ Debt — 1 1 1
Other — 0 0 —
— 9 3 3

Compound Annual Growth %

10y 5y 3y
Sales — — —
Cash Flow — — —
Earnings — — —
Book Value — — —

Revenue $m

Mar Jun Sep Dec Year
’26 — — — — —
’25 — — — — 5
Fiscal quarters ending in the months shown.

Operating Cash Flow $m

Mar Jun Sep Dec Year
’26 — — — — —
’25 — — — — (1)
Fiscal quarters ending in the months shown.

Free Cash Flow $m

Mar Jun Sep Dec Year
’26 0 — — — —
’25 0 — (1) — (1)
Fiscal quarters ending in the months shown.

EPS $

Mar Jun Sep Dec Year
’26 — — — — —
’25 — — — — (0.10)
Fiscal quarters ending in the months shown.

Target Price Range

Analyst price targets

Recommendation Rating

1Buy 2 3Hold 4 5Sell

Ten years at a glance Fiscal years to September

Group Line 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 Trend 2026e 2027e 2028e
Price, $
Price, $ Low — — — — — — — — — 0.35

Analyst estimates 2026–2028

Powerpack
High — — — — — — — — — 5.40
People
People Employees — — — — — — — — 7 7
Revenue/emp, $m — — — — — — — — 1.78 0.69
Income, $m
Income, $m Revenue — — — — — — — — 12 5
Gross margin, % — — — — — — — — 6.18 2.78
EBT — — — — — — — — 0 (2)
EBT margin, % — — — — — — — — (0.78) (43.00)
Net income — — — — — — — — 0 (2)
Depreciation — — — — — — — — 0 0
Per share, $
Per share, $ Revenue — — — — — — — — 0.69 0.26
Earnings — — — — — — — — (0.01) (0.10)
Cash flow — — — — — — — — 0.12 (0.05)
Capex — — — — — — — — 0.00 0.00
Free cash flow — — — — — — — — 0.12 (0.05)
Book value — — — — — — — — (0.06) 0.34
Shares, m — — — — — — — — 18 18
Valuation, ×
Valuation, × P/E — — — — — — — — — —
P/S — — — — — — — — — —
P/B — — — — — — — — 0.00 0.00
EV/Sales — — — — — — — — 0.00 0.00
EV/FCF — — — — — — — — 0.00 0.00
Cash, $m
Cash, $m Operating cash flow — — — — — — — — 2 (1)
Capex — — — — — — — — — —
Free cash flow — — — — — — — — 2 (1)
Balance, $m
Balance, $m Working capital — — — — — — — — (1) 6
Total debt — — — — — — — — 1 1
Net debt — — — — — — — — 1 (4)
Shareholders’ equity — — — — — — — — (1) 6
Returns, %
Returns, % ROA — — — — — — — — 0.00 (20.35)
ROIC — — — — — — — — (0.04) (49.29)
ROE — — — — — — — — 0.00 (67.61)
Negative figures in brackets.

All 10 years →

Fiscal years to Sep 2025

Charts ten years each

Ping An Biomedical Co., Ltd. vs peers in Textile Manufacturing (Q) = latest quarter vs a year earlier

Company Market cap P/E Fwd P/E Revenue growth (Q) EPS growth (Q) FCF growth (Q) Gross margin (Q) EBIT margin (Q) Compare
AIN Albany International Corporation $1.7B — (loss-making) 23.0× +5.81% (above 0%: growing) +96.77% (above 0%: growing) −181.79% (below 0%: shrinking) 32.75% 9.75% Compare
UFI Unifi, Inc. $111.0M — (loss-making) 68.5× +4.11% (above 0%: growing) n/m +104.26% (above 0%: growing) 9.94% 1.65% Compare
SMJF SMJ International Holdings Inc. $57.4M — — — — — — — Compare
CULP Culp, Inc. $48.7M — (loss-making) 11.6× +6.47% (above 0%: growing) n/m +8,365.22% (above 0%: growing) 28.49% 12.36% Compare
PASW Ping An Biomedical Co., Ltd. $16.7M — — — — — — —
DXYN The Dixie Group, Inc. $13.8M — (loss-making) — (loss-making) +0.06% (above 0%: growing) 0.00% +2.36% (above 0%: growing) 29.49% 4.51% Compare
Median of peers $57.4M — 23.0× +4.96% — +53.31% 28.99% 7.13%

All 6 Textile Manufacturing stocks →

Ping An Biomedical Co., Ltd. (PASW) key facts

  • Concern: Ping An Biomedical Co., Ltd.’s revenue for fiscal 2025 (year ended September 2025) was $4.8 million, down 61.6% from fiscal 2024.
  • Concern: Ping An Biomedical Co., Ltd. reported a net loss of $1.8 million, or a loss of $0.10 per share, for fiscal 2025.
  • Ping An Biomedical Co., Ltd. (PASW) is a Textile Manufacturing company in the Consumer Cyclical sector, listed on Nasdaq.
  • As of October 16, 2026, PASW traded at $0.12, a market capitalization of $16.7 million.
  • Return on equity was −67.6% and debt-to-equity 0.13.
  • Its Altman Z-score is 4.30 (safe zone) for fiscal 2025.

Source: company filings (standardised) and stockrow calculations.

Ping An Biomedical Co., Ltd. (PASW) Latest News

stockrow.com/PASW · Data as of Sep 30, 2025 · For information only; not investment advice. · © 2026 stockrow.com